Dacogen 50 mg powder for concentrate for solution for infusion., Venclyxto 100 mg film-coated tablets clinical trials

Phase II study on Venetoclax (VEN) plus Decitabine (DEC) (VEN-DEC) for elderly (≥60 <75years) patients with newly diagnosed Acute Myeloid Leukemia (AML) elegible for allogeneic Stem Cell Transplantation (allo-SCT)

This study looks at a new treatment called Venetoclax plus Decitabine for older patients (60-74 years) with a type of blood cancer called Acute Myeloid Leukemia (AML). It aims to see if this treatment helps them get a stem cell transplant, which can be a cure for AML.